Skip to main content

Table 1 Baseline characteristics

From: Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study

  Acetylsalicylic acid Acetylsalicylic acid + dipyridamole Clopidogrel p-value
(n = 3043) (n = 12,295) (n = 3885)
Age in years, median (IQR) 75.3 (64.4–83.7) 70.7 (61.5–79.6) 68.6 (59.2–77.6) >0.0001
Men (%) 47.5 % 56.5 % 49.3 % >0.0001
Diabetes 380 (12.5 %) 1449 (11.8 %) 455 (11.7 %) 0.5263
Hypertension 1316 (43.2 %) 4987 (40.6 %) 1644 (42.3 %) 0.0102
Myocardial infarction 334 (11 %) 824 (6.7 %) 523 (13.5 %) <0.01
Peripheral artery disease 126 (4.1 %) 297 (2.4 %) 180 (4.6 %) <0.01
Heart failure 222 (7.3 %) 496 (4 %) 229 (5.9 %) <0.01
Cancer 206 (6.8 %) 714 (5.8 %) 245 (6.3 %) 0.1062
Chronic obstructive pulmonary disease 256 (8.4 %) 808 (6.6 %) 274 (7.1 %) <0.01
Previous bleeding 405 (13.3 %) 853 (6.9 %) 319 (8.2 %) <0.01
NSAIDS 485 (15.9 %) 1751 (14.2 %) 600 (15.4 %) 0.0243